Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant

PURPOSE: This analysis assesses clinical characteristics of patients with refractory chronic cough (RCC) or unexplained chronic cough (UCC) enrolled in a phase 2 study to better understand this patient population. METHODS: Patients with RCC/UCC lasting for ≥ 1 year and cough severity visual analog s...

Descripción completa

Detalles Bibliográficos
Autores principales: Morice, Alyn H., Birring, Surinder S., Smith, Jaclyn A., McGarvey, Lorcan P., Schelfhout, Jonathan, Martin Nguyen, Allison, Xu, Zhi Jin, Wu, Wen-Chi, Muccino, David R., Sher, Mandel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Cough
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053171/
https://www.ncbi.nlm.nih.gov/pubmed/33825965
http://dx.doi.org/10.1007/s00408-021-00437-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053171/
https://www.ncbi.nlm.nih.gov/pubmed/33825965
http://dx.doi.org/10.1007/s00408-021-00437-7

Ejemplares similares